MRVL vs VRTV: Which Is the Better Buy?

Side-by-side comparison of Marvell Technology, Inc. and Veritiv Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
Marvell Technology, Inc. Β· Technology
$258.95
-11.4% upside to fair value
Med Conviction Grade C High Quality
VS
Veritiv Corporation Β· Industrials
$169.99
-45.0% upside to fair value
Med Conviction Grade D
QuantHub Verdict
MRVL has more upside to fair value (-11.4%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MRVL VRTV
Current Price $258.95 $169.99
Fair Value Estimate $229.46 $93.49
Upside to Fair Value -11.4% -45.0%
Market Cap $226.8B $2.3B
Forward P/E β€” β€”
EV / EBITDA 48.0x 5.4x
Price / Sales 24.0x 0.4x
Price / FCF 134.3x 10.4x
Revenue Growth YoY +36.5% -19.0%
Gross Margin 51.4% 22.7%
Operating Margin 16.7% 5.9%
Return on Equity 16.2% 48.6%
Dividend Yield 0.09% 1.48%
FCF Yield 0.74% 9.57%
Analyst Consensus Strong Buy Hold
Investment Thesis
MRVL β€” Marvell Technology, Inc.
Marvell Technology is a data infrastructure semiconductor specialist that designs custom AI accelerators, electro-optics DSPs, ethernet switching, storage controllers and interconnect silicon for hyperscale data centers, communications and carrier markets, employing roughly 7,480 people under CEO Matthew J. Murphy. Business quality is genuinely high on the demand side: revenue grew 36.5% year ove…
VRTV β€” Veritiv Corporation
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year in…
Accumulation Zones
Metric MRVL VRTV
Zone Low $172.09 $70.12
Zone High $195.04 $79.47
In Buy Zone? No No
← MRVL Research    VRTV Research β†’    All Research